PAPER Morgese MG, Tucci P, Colaianna M, Zotti M, Cuomo V, Schiavone S, Trabace L
SEARCH RESULTS
330026 RESULTS
PAPER Govoni S, Mura E, Preda S, Racchi M, Lanni C, Grilli M, Zappettini S, Salamone A, Olivero G, Pittaluga A, Marchi M
Dangerous Liaisons between Beta-Amyloid and Cholinergic Neurotransmission.
Curr Pharm Des. 2013 Jul 11; PubMed: 23859550PAPER Osorio RS, Gumb T, Pomara N
Soluble Amyloid-β Levels and Late-Life Depression.
Curr Pharm Des. 2013 Jul 11; PubMed: 23859552PAPER Balducci C, Forloni G
In Vivo Application of Beta Amyloid Oligomers: a Simple Tool to Evaluate Mechanisms of Action and New Therapeutic Approaches.
Curr Pharm Des. 2013 Jul 11; PubMed: 23859553PAPER Agholme L, Hallbeck M
Getting Rid of Intracellular Aβ- Loss of Cellular Degradation Leads to Transfer.
Curr Pharm Des. 2013 Jul 11; PubMed: 23859554PAPER Portelius E, Appelkvist P, Strömberg K, Hoglund K
Characterization of the Effect of a Novel γ-Secretase Modulator on Aβ: A Clinically Translatable Model.
Curr Pharm Des. 2013 Jul 11; PubMed: 23859556PAPER Attar A, Bitan G
Disrupting Self-Assembly and Toxicity of Amyloidogenic Protein Oligomers by "Molecular Tweezers"- from the Test Tube to Animal Models.
Curr Pharm Des. 2013 Jul 11; PubMed: 23859557PAPER Anumala UR, Gu J, Lo Monte F, Kramer T, Heyny-von Haussen R, Hölzer J, Goetschy-Meyer V, Schön C, Mall G, Hilger I, Czech C, Herms J, Schmidt B
Fluorescent rhodanine-3-acetic acids visualize neurofibrillary tangles in Alzheimer's disease brains.
Bioorg Med Chem. 2013 Sep 1;21(17):5139-44. PubMed: 23859773PAPER Nutu M, Zetterberg H, Londos E, Minthon L, Nägga K, Blennow K, Hansson O, Ohrfelt A
Evaluation of the Cerebrospinal Fluid Amyloid-β1-42/Amyloid-β1-40 Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders.
Dement Geriatr Cogn Disord. 2013;36(1-2):99-110. PubMed: 23860354PAPER Abraham JD, Promé S, Salvetat N, Rubrecht L, Cobo S, du Paty E, Galéa P, Mathieu-Dupas E, Ranaldi S, Caillava C, Crémer GA, Rieunier F, Robert P, Molina F, Laune D, Checler F, Fareh J
Cerebrospinal Aβ11-x and 17-x levels as indicators of mild cognitive impairment and patients' stratification in Alzheimer's disease.
Transl Psychiatry. 2013 Jul 16;3:e281. PubMed: 23860482PAPER Katsel P, Tan W, Fam P, Purohit DP, Haroutunian V
Cycle checkpoint abnormalities during dementia: a plausible association with the loss of protection against oxidative stress in Alzheimer's disease.
PLoS One. 2013;8(7):e68361. PubMed: 23861893PAPER Birks J, Craig D
Galantamine for vascular cognitive impairment.
Cochrane Database Syst Rev. 2013;4:CD004746. PubMed: 23862185PAPER Kozauer N, Katz R
Regulation of drugs for early Alzheimer's disease.
N Engl J Med. 2013 Jul 18;369(3):288. PubMed: 23863069PAPER Light DW, Darrow J
Regulation of drugs for early Alzheimer's disease.
N Engl J Med. 2013 Jul 18;369(3):288. PubMed: 23863070PAPER Olazarán J, Martínez MD, Rábano A
Normal pressure hydrocephalus mimicking Alzheimer's disease: such an infrequent case?
Clin Neuropathol. 2013 Jul 17; PubMed: 23863346Current Filters
No filters selected